Aspira Women's Health Board Changes
Ticker: AWHL · Form: 8-K · Filed: Jun 27, 2024 · CIK: 926617
| Field | Detail |
|---|---|
| Company | Aspira Women'S Health INC. (AWHL) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation
TL;DR
Aspira Women's Health swapped a director and updated executive pay on 6/27.
AI Summary
Aspira Women's Health Inc. announced on June 27, 2024, a change in its board of directors. Specifically, the company reported the departure of Director Dr. Michael J. McNeely and the election of Dr. David L. Smith as a new Class III director. The company also disclosed compensatory arrangements for certain officers.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine board and officer changes and compensatory arrangements, which are common corporate events.
Key Players & Entities
- Aspira Women's Health Inc. (company) — Registrant
- Dr. Michael J. McNeely (person) — Departing Director
- Dr. David L. Smith (person) — Newly Elected Director
- June 27, 2024 (date) — Date of Report
FAQ
Who has been elected as a new Class III director for Aspira Women's Health Inc.?
Dr. David L. Smith has been elected as a new Class III director.
Which director has departed from Aspira Women's Health Inc.'s board?
Dr. Michael J. McNeely has departed from the board.
What is the exact date of the report for these changes?
The date of the report is June 27, 2024.
What other item is Aspira Women's Health Inc. reporting in this 8-K filing besides director changes?
The company is also reporting on compensatory arrangements of certain officers.
What is the state of incorporation for Aspira Women's Health Inc.?
The state of incorporation is Delaware.
Filing Stats: 757 words · 3 min read · ~3 pages · Grade level 12.1 · Accepted 2024-06-27 17:21:52
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share AWH Nasdaq Capital Market
Filing Documents
- awh-20240627.htm (8-K) — 58KB
- awh-ex10_1.htm (EX-10.1) — 21KB
- 0000950170-24-078612.txt ( ) — 202KB
- awh-20240627.xsd (EX-101.SCH) — 31KB
- awh-20240627_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASPIRA WOMEN'S HEALTH INC. Date: June 27, 2024 By: /s/ Nicole Sandford Nicole Sandford Chief Executive Officer